Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04759183 · ClinicalTrials.gov registry record · NA
Virtual Reality Experiences for Anxiety and Pain Control
A NA study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT04759183: Completed NA study, sponsored by OHSU Knight Cancer Institute.
NCT04759183 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04759183, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This trial studies the impact of virtual reality experiences on anxiety before surgery and pain after surgery. The goal of this study is to examine how different virtual reality experiences may help reduce anxiety and improve pain control, which may help reduce the need for medications such as opioids.
Primary Outcome
Assessed by visual analogue scale (VAS) from 0-100mm.
Interventions
- OTHER Survey Administration
- PROCEDURE Virtual Reality Game
- PROCEDURE Virtual Reality Meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2021-03-05 |
| Est. Completion | 2022-08-25 |
| Phase | NA |
What the finished NCT04759183 record still lists
NCT04759183 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT04759183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04759183 about?
NCT04759183 is a clinical study titled "Virtual Reality Experiences for Anxiety and Pain Control". This trial studies the impact of virtual reality experiences on anxiety before surgery and pain after surgery. The goal of this study is to examine how different virtual reality experiences may help reduce anxiety and improve pain control, which may help reduce the need for medications such as opioi...
What is the current status of trial NCT04759183?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2021-03-05. Estimated completion is 2022-08-25.
What interventions are being tested in trial NCT04759183?
The interventions under investigation include: Survey Administration (OTHER), Virtual Reality Game (PROCEDURE), Virtual Reality Meditation (PROCEDURE).
Who is sponsoring clinical trial NCT04759183?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04759183's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI